![]() ![]() ![]() ![]() Since we are using a half-wave dipole, G R is equal to 0. First, we must know how many microvolts would appear across the terminals of a half-wave dipole when placed in a field strength of 25 µV/m. From this information, we can determine the amount of gain of the internal antenna in dBd. Suppose the sensitivity of a voice pager is given as 25 µV/m (microvolts per meter) in terms of field strength, or 0.5 µV chassis sensitivity, at a frequency of 160 MHz. This article will describe the relationship between several of the more frequently used units of measure and how they are applied in practice. We look forward to working closely and strategically with our distribution partner in Japan to further expand that market and maximize the value of the relationship.It is imperative that wireless communication technicians understand the various units of measurement used to quantify the level or amplitude of a radio frequency, or RF, signal. “Gaining reimbursement coverage in Japan, which enjoys one of the most advanced healthcare systems in the world, is an important milestone for our MTWA technology and another indicator that the value of MTWA testing is being recognized around the world. “This decision highlights the valuable role that MTWA can play in managing a patient’s risk for sudden cardiac arrest,” Haghighi-Mood said. A large body of clinical evidence supports the predictive value of the test which can now be used more broadly to help identify and manage the risk of life-threatening arrhythmias.”Ĭambridge Heart markets its MTWA technology in Japan through its partnership with Fukuda Denshi Corporation, one of Japan’s leading and most active medical device and technology companies, which has already established an MTWA user base in the country, noted Ali Haghighi-Mood, Cambridge Heart president and CEO. Takanori Ikeda, Professor of Medicine at Toho University Medical Center, said, “We are very pleased with the reimbursement decision on MTWA testing. ![]() Effective April 1, 2012, the MTWA Test will be reimbursed for patients who are considered at risk for lethal arrhythmias including, but not limited to, patients with a history of heart attack, cardiomyopathy and Brugada syndrome.Ĭommenting on the decision, Dr. MaCambridge Heart Inc., a developer of non-invasive diagnostic tests for cardiac disease, announced that its Microvolt T-Wave Alternans (MTWA) test received reimbursement coverage from Japan’s Ministry of Health, Labor and Welfare (MHLW). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |